In a study using the HaCaT human keratinocyte cell line, an aqueous solution from Ashwagandha root was found to inhibit the NF-B and MAPK (mitogen-activated protein kinase) pathways by decreasing the expression of proinflammatory cytokines, including interleukin (IL)-8, IL-6, tumour necrosis factor (TNF-), IL-1, and IL-12, and increasing the expression of anti-inflammatory cytokines
[1] [2] A higher-dose formulation called Wegovy (also semaglutide, but at 2.4 mg) is specifically licensed for weight management in the UK, where clinical trials have shown average weight loss of 10-15% when combined with lifestyle changes
Exendin-4 regulates Gila Monster blood sugar levels
Every morsel needs to be appreciated for better digestion
Clinical investigations demonstrate that GLP-1RA therapy exhibits superior therapeutic efficacy in patients without hepatic steatosis compared to those with fatty liver disease [42]